This inventor holds 1 USPTO granted patent. Top assignees: Nanocarrier Co., Ltd., National Cancer Center, Riken Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2018
Title: The Innovations of Ryuta Sato
Introduction
Ryuta Sato is a notable inventor from Kashiwa, Japan, known for his contributions to the field of biomedicine, particularly through his work on monoclonal antibodies. With a focus on therapeutic methods and drug delivery systems, he has made significant strides in addressing health challenges related to tissue factors.
Latest Patents
Ryuta Sato holds a patent for an "Anti-tissue factor monoclonal antibody." This patent includes details on monoclonal antibodies that target human and mouse tissue factors, along with their fragments. It also encompasses various pharmaceutical compositions and drug delivery systems utilizing these antibodies. The therapeutic methods outlined in this patent provide potential advancements in medical treatments.
Career Highlights
Throughout his career, Ryuta Sato has collaborated with prominent institutions, working with the National Cancer Center and The University of Tokyo. His research has significantly contributed to the understanding and development of innovative solutions in cancer therapies and other related fields.
Collaborations
In his professional journey, Sato has partnered with other esteemed researchers, including Yasuhiro Matsumura and Masahiro Yasunaga. These collaborations have further enhanced the development of his inventions and the impact of his work in the scientific community.
Conclusion
Ryuta Sato exemplifies the spirit of innovation in biomedical research. His patented work on monoclonal antibodies represents a crucial advancement that could lead to improved therapeutic options for patients. As an inventor, his contributions continue to inspire future research and development in health sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile